Application Notes & Case Studies

  1. Column Selection For RPLC-UV Impurity Analysis 7/17/2025

    Explore the performance of four column chemistries for RPLC-UV impurity analysis of liraglutide and semaglutide, which offers practical guidance for method development in peptide-based therapeutics.

  2. UPLC-MS/MS Determination Of GLP-1 Analogue 7/17/2025

    Discover a robust, evaporation-free method for analyzing liraglutide in human plasma using LC-MS/MS to ensure high sensitivity, reproducibility, and improved analyte recovery.

  3. Quantification Of Semaglutide With A Reliable Analytical Method 7/17/2025

    Explore a validated LC-MS/MS method for precise Semaglutide quantification in plasma, which features enhanced sensitivity, peak definition, and reproducibility using innovative technologies.

  4. Developing A Quantitative Surrogate Peptide Assay 7/17/2025

    Discover a streamlined LC-MS/MS workflow for Fc-containing therapeutics like dulaglutide to enable precise quantification with LLOQ as low as 1 ng/mL through automated, efficient assay development.

  5. Development Of An Effective LC-MS/MS Cleaning Validation Method 7/17/2025

    Gain insight into a robust LC-MS/MS method for quantifying therapeutic peptides that supports contamination control and cleaning validation to ensure product safety and integrity.

  6. Bioanalytical Quantification Of A Biotherapeutic Peptide 7/17/2025

    Discover a sensitive, selective, and robust LC-MS method for quantifying semaglutide in plasma with advanced sample preparation and detection technologies for accurate results in bioanalytical research.

  7. Comparative Analysis Of Batch And Continuous Processes 7/10/2025

    Explore a comparative analysis that showcases the superior performance of continuous processing over traditional batch methods, highlighting key improvements in efficiency and environmental impact.

  8. Use Of Reconstructed Tissue And 3D Printed CT-Based Nasal Casts 7/3/2025

    Reconstructed nasal epithelium and CT-based 3D nasal casts provide more predictive, physiologically relevant models for assessing nasal drug delivery, improving accuracy in formulation development.

  9. Client Story: Efficiency Enabling CSV At Scale 7/1/2025

    Discover how Fujirebio Diagnostics digitized their global CSV processes to achieve a 53% time reduction in CAPA projects and streamline validation with remarkable efficiency gains.

  10. N-1 Perfusion High Inoculum Fed-Batch For Reduced COGS And Easy Retrofit 6/30/2025

    Discover a company that tripled productivity and cut costs by optimizing its seed train process to achieve major gains without infrastructure expansion.